M. Nakanishi et al., DISTINCT CLONOTYPIC EPSTEIN-BARR VIRUS-INDUCED FATAL LYMPHOPROLIFERATIVE DISORDER IN A PATIENT WITH WISKOTT-ALDRICH SYNDROME, Cancer, 72(4), 1993, pp. 1376-1381
Background. Recently, reports of Epstein-Barr virus (EBV)-induced lymp
hoproliferative disorders (LPD) have increased in number among immunos
uppressed recipients of organ transplants. The importance of analyzing
both the immunoglobulin gene and EBV termini is advocated for the inv
estigation of pathogenetic mechanisms for clonal proliferation in EBV-
induced LPD; however, the oncogenic mechanisms of EBV-induced LPD rema
in unclear. Furthermore, there are very few clonotypic studies of EBV-
induced LPD in patients with primary immunodeficiency diseases. The au
thors studied the clonality of an EBV-induced fatal LPD in a 20-year-o
ld patient with Wiskott-Aldrich syndrome (WAS), an X-linked recessive
primary immunodeficiency disease. Methods and Results. An autopsy show
ed non-Hodgkin lymphoma of B-cell origin with diffuse large cells in b
oth systemic lymph nodes and extranodal organs. Immunohistochemical an
d Southern blot analyses showed polyclonal rearrangement of immunoglob
ulin genes in most of the lesions except for the pulmonary hilar lymph
node. Furthermore, the analysis of restriction fragment length polymo
rphism with several fragments from EBV genome indicated that EBV genom
es in all lesions were identical; however, a single but different-size
d EBV termini was detected in every EBV-positive lesion when probed wi
th the EcoRI-Dhet spanning terminal repeat region of EBV. Conclusions.
The EBV-induced fatal LPD in a patient with WAS showed the characteri
stic clonotype, polyclonal immunoglobulin gene rearrangement, and mono
clonal EBV terminal configuration. Furthermore, EBV termini in each le
sion varied in size. This particular clonotype implicates several uniq
ue pathogenetic mechanisms for clonal proliferation of EBV-induced LPD
.